Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
about
sameAs
Barrett's oesophagus and adenocarcinomaSignaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionThe tumor microenvironment in esophageal cancerOesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesisRisk of cancer in a large cohort of nonaspirin NSAID users: a population-based studyMolecular changes in the progression of Barrett's oesophagusRole of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experienceCyclooxygenase inhibitors use is associated with reduced risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a meta-analysisNon-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems.Chemoprevention of esophageal adenocarcinomaNonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagusThe HGF receptor c-Met is overexpressed in esophageal adenocarcinoma.Elevated serum gastrin is associated with a history of advanced neoplasia in Barrett's esophagus.Biomarkers in exploring the frontiers of diagnosis, prognosis, and therapy of Barrett's esophagus.Review: Experimental models for Barrett's esophagus and esophageal adenocarcinomaCox2 and β-catenin/T-cell factor signaling intestinalize human esophageal keratinocytes when cultured under organotypic conditionsPredictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.TP53 and progression from Barrett's metaplasia to oesophageal adenocarcinoma in a UK population cohortBarrett's Esophagus: Emerging Knowledge and Management StrategiesAspirin protects against Barrett's esophagus in a multivariate logistic regression analysis.Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma.Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence.COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ.Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagusPrediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.Medication usage and the risk of neoplasia in patients with Barrett's esophagus.Forthcoming prognostic markers for esophageal cancer: a systematic review and meta-analysis.Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis.Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions.Proton Pump Inhibitors: The Culprit for Barrett's Esophagus?COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma.Inflammation-related carcinogenesis and prevention in esophageal adenocarcinoma using rat duodenoesophageal reflux models.Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.Helicobacter pylori induces caudal-type homeobox protein 2 and cyclooxygenase 2 expression by modulating microRNAs in esophageal epithelial cells.
P2860
Q24791935-285FD592-97EE-45A8-B934-72AAB67A4D11Q27026253-4ECF349D-101E-4897-86A7-C0DA5BA81837Q28077074-BAAC2360-A6C3-4768-B921-35F7C9017E98Q28195678-858B2218-161D-4544-83E4-0C13A92B1DACQ28196301-4CAB04DA-C24B-48B1-BF68-D5CC36A78E88Q28219148-2D028044-E93A-4CD2-ACF3-549A492EAB4DQ28303196-21E1B218-9B56-4009-A456-1CA1ADE6F95AQ33555216-F4CDE3AA-ABF5-4A25-A731-B96239528D1DQ33664095-C2AF9FBE-B400-436F-A839-26247139C371Q33905941-1E092E36-042D-41B5-8062-5B56596AB988Q34143148-9FE4D9D7-CBE4-4627-A89A-12CF8B0D9469Q34408890-BD412999-9B54-4A5B-9E64-8DCC4CA85CCCQ34429198-9B44789D-4BDA-4CB1-962A-3E229682F3A3Q34724977-8A922F34-CEE3-4F70-93B8-A8DAC8A78283Q35116562-E471D9E0-9CED-43F1-8ECF-8C9B6CA38A03Q35216586-3214B9CB-F3CA-4F2F-AA66-6BA8FC51B1CFQ35235311-7B99F7B5-90E8-4D29-8E93-F18347E87739Q35238056-C6E1308A-F716-4CE9-8148-C390D8399858Q35666515-971D03AA-E921-4910-80DB-592EAB941FA5Q35760858-E089265E-DD71-4BBA-9113-65519982C2BDQ36014649-65EA1D2B-A0BE-4BE7-BE85-EDEB9E2E7584Q36212679-EE15067F-857D-406E-898A-81B7BDB0A59FQ36370513-24B2EA7A-9D4D-43F1-ABD8-D8B35B0F1EBEQ36510119-F32FD05F-2C83-4FE4-B138-51796899CF8CQ36610386-A1451F34-D7B0-4DC7-BD04-4FD53D78472EQ36694470-F0B21DBD-3BB4-4B96-90ED-120AAD825AB3Q37050199-F1975610-1BDF-4277-B66A-0E50C6243668Q37361447-8A3163FC-BE64-4E7F-ACC4-C6F34AF4D9E8Q37463812-BF560935-21A2-4EA6-A358-B3FF0DA8C280Q37522222-B1AAF6A8-8EA1-41C7-A810-CDBD6C888626Q37554702-15E711E4-91E2-4453-9179-E5BB976CF4DCQ37633568-75C9B1A8-9390-4703-9811-788B3AE21FBDQ37809363-F6274EB2-5E9C-4FC9-9BBF-9092198EA731Q37967701-D20B9015-B5D8-4A16-877E-E8EA36C0D502Q38332589-4909C42C-5E11-40D4-8C9D-C25B84359163Q40690849-8E22443E-A0ED-48A2-8AD4-D4E469E38E77Q41783023-A1BB38A3-4806-4029-AA54-B0D827E4FCB4Q46835399-A49F7594-9F96-4451-A9F6-8DF254669C44Q48159599-4B0D15B8-218B-437B-B8D8-9F3FA79C8259
P2860
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@ast
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@en
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@nl
type
label
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@ast
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@en
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@nl
prefLabel
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@ast
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@en
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@nl
P2093
P3181
P1476
Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence
@en
P2093
C D Morris
G R Armstrong
S E Attwood
P3181
P356
10.1016/S0002-9270(00)02392-3
P407
P577
2001-04-01T00:00:00Z